Abstract:Background: Based on network pharmacology, molecular docking, and vitro assays, investigate the probable pharmacological mechanism of Dioscoreae bulbiferae and Bruceae fructus in the treatment of laryngocarcinoma. Methods: The active components and targets of Dioscoreae bulbiferae and Bruceae fructus were retrieved from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform database. Targets linked with laryngocarcinoma were gathered from the GeneCards, DisGeNET, and DrugBank databases. The String database was utilized to build a protein-protein interaction network of common medication and illness targets, after which the core targets were filtered out. The Metascape database served for gene ontology enrichment and Kyoto encyclopedia of genes and genomes pathway analysis of common targets. AutoDock then performed molecular docking between the essential component and the vital target. To investigate the biological effects of diosbulbin B, we assessed the viability of laryngocarcinoma cells after diosbulbin B therapy using the Mahalanobis Taguchi system technique. Following that, we looked at how diosbulbin B affected colony formation after 14 days of culture of treated cells. Flow cytometry was utilized to detect apoptosis in order to examine the influence of diosbulbin B on laryngocarcinoma cell apoptosis. Results: According to a study of the literature, the fundamental components of Dioscoreae bulbiferae and Bruceae fructus in the treatment of laryngocarcinoma include brusatol and diosbulbin B, which may operate on core targets such as cyclin D1, Cyclin Dependent Kinase Inhibitor 1A, and E2F Transcription Factor 1. The significant pathways discovered using Kyoto encyclopedia of genes and genomes enrichment analysis were the phosphoinositide 3-kinase-protein kinase B signaling route, the tumor necrosis factor signaling pathway, and so on. These pathways primarily influence the development and prognosis of laryngeal cancer by controlling cell growth, cell proliferation, angiogenesis, tumorigenesis, and metastasis. The molecular docking studies revealed that the affinity between the heart and crucial targets was robust. The results of vitro assays indicate that diosbulbin B suppressed Hep-2 cell activity in a concentration-dependent manner. Besides, diosbulbin B has powerful antiproliferative properties in Hep-2 cells. Flow cytometry results showed that diosbulbin B promoted laryngocarcinoma cell apoptosis in a concentration-dependent manner. Conclusion: The article delivered a preliminary discussion of the probable mechanism of Dioscoreae bulbiferae and Bruceae fructus in the treatment of laryngocarcinoma, which can serve as a theoretical basis and evidence for subsequent experimental investigation.

Antitumor activity of Dioscorea bulbifera L. rhizome in vivo.

Diterpenoid C Extracted from Radix Curcumae Inhibits Proliferation and Induces Apoptosis of Colonic Adenocarcinoma Cells

Diosbulbin C, a novel active ingredient in Dioscorea bulbifera L. extract, inhibits lung cancer cell proliferation by inducing G0/G1 phase cell cycle arrest

Inhibiting Effect of Tumor by Dendrobium denneanum

Metabolism of diosbulbin B in vitro and in vivo in rats: formation of reactive metabolites and human enzymes involved.

Steroidal saponins from the rhizomes of Dioscorea bulbifera and their cytotoxic activity.

Diosbulbin B-induced liver injury in mice and its mechanism.

Diosbulbin B: An important component responsible for hepatotoxicity and protein covalent binding induced by Dioscorea bulbifera L.

[Extraction and Anti-Tumor Activity Study of Polysaccharide in Several Traditional Chinese Medicine].

Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry

Prediction of network pharmacology, molecular docking-based strategy, and vitro assays to determine potential pharmacological mechanism of Dioscoreae bulbiferae and Bruceae fructus against laryngocarcinoma

Chemical constituents from the rhizome of Dioscorea bulbifera L.

The anti-non-small cell lung cancer effect of Diosbulbin B: Targeting YY1 induced cell cycle arrest and apoptosis

Liver-specific Metabolomics Characterizes the Hepatotoxicity of Dioscorea Bulbifera Rhizome in Rats by Integration of GC-MS and 1H-NMR.

Toxicity of a Diterpene Lactone Isolated from Dioscorea bulbifera on Hepatocytes

Anticancer Activity of Diosgenin and Its Molecular Mechanism

Research Progress and Strategy in Toxicity of Dioscorea Bulbifera Rhizome with Main Bioactivity of Antitumor Action

The HPLC–MS/MS Method for Determination of Diosbulbin B in the Plasma of Rats Administered with Rhizoma Dioscoreae Bulbiferae Combinations: Application to Comparative Pharmacokinetic Study

Evaluation of anti-tumor activity of water-soluble polysaccharides from Dendrobium denneanum

Scutellarin Protects Against the Liver Injury Induced by Diosbulbin B in Mice and Its Mechanism.

Cytotoxicity and Apoptosis-Inducing Effect of Steroidal Saponins from Dioscorea Zingiberensis Wright Against Cancer Cells